The Penghua SSE Science and Technology Innovation Board 200 ETF is actively traded, with pharmaceuticals and commercial aerospace thriving against the trend

Today, the pharmaceutical and medical sectors, as well as commercial aerospace, are actively defying the trend. On March 30th, the "Lijian No. 2" remote one launch vehicle was successfully launched, igniting the commercial aerospace sector. Significant breakthroughs in CAR-T technology provide new ideas for cancer immunotherapy. Market sentiment remains cautious, with attention on the situation across the Taiwan Strait and earnings report disclosures. The latest quote for the Penghua SSE Science and Technology Innovation Board 200 ETF is 1.48 yuan, with good liquidity, averaging a daily transaction of 69.3284 million yuan over the past month. Among the constituent stocks of the Science and Technology Innovation Board 200 Index, the proportion of "specialized, refined, distinctive, and innovative small giants" reaches 69%